Exact Mass: 325.2042

Exact Mass Matches: 325.2042

Found 86 metabolites which its exact mass value is equals to given mass value 325.2042, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

dinor-Levomethadyl acetate

1 alpha-Acetyldinormethadol, hydrochloride, (S-(r*,r*))-isomer

C21H27NO2 (325.2042)


dinor-Levomethadyl acetate is a metabolite of levomethadyl acetate. Levacetylmethadol, levomethadyl acetate, Orlaam (trade name) or levo-α-acetylmethadol (LAAM) is a synthetic opioid similar in structure to methadone. It has a long duration of action due to its active metabolites. (Wikipedia)

   

Farnesylcysteine

(2R)-2-amino-3-{[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]sulfanyl}propanoic acid

C18H31NO2S (325.2075)


In patients with chronic fatigue syndrome (CFS) we found increased IgM levels to S-farnesyl-L-cysteine. S-farnesyl-L-cysteine plays a key role in regulating cell growth, differentiation and apoptosis through RAS protein activity. The latter depends on their anchorage to the inner surface of the plasma membrane, which is promoted by their common carboxy-terminal S-farnesyl-cysteine. The presence of antibodies to S-farnesyl-L-cysteine suggest that RAS functions may have undergone damage by oxidative/nitrosative stress, causing disturbed functional activity in the regulation of cell growth. (PMID 17159817).

   

Norpropoxyphene

3-Methyl-4-(methylamino)-1,2-diphenylbutan-2-yl propanoic acid

C21H27NO2 (325.2042)


Norpropoxyphene is a major metabolite of the opioid analgesic drug dextropropoxyphene, and is responsible for many of the side effects associated with use of this drug, especially the unusual toxicity seen during dextropropoxyphene overdose. It has weaker analgesic effects than dextropropoxyphene itself, but is a relatively potent pro-convulsant and blocker of sodium and potassium channels, particularly in heart tissue, which produces prolonged intracardiac conduction time and can lead to heart failure following even relatively minor overdoses. The toxicity of this metabolite makes dextropropoxyphene up to 10 times more likely to cause death following overdose compared to other similar mild opioid analgesics, and has led to dextropropoxyphene being withdrawn from the market in some countries.

   

Aprofene

2,2-Diphenylpropanoic acid N,N-diethylaminoethyl ester

C21H27NO2 (325.2042)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent

   

Isoleucyl-prolyl-proline

1-[1-(2-amino-3-methylpentanoyl)pyrrolidine-2-carbonyl]pyrrolidine-2-carboxylic acid

C16H27N3O4 (325.2001)


   

L-Proline, 1-(1-L-leucyl-L-prolyl)-

1-[1-(2-amino-4-methylpentanoyl)pyrrolidine-2-carbonyl]pyrrolidine-2-carboxylic acid

C16H27N3O4 (325.2001)


   

Ifenprodil

alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine ethanol

C21H27NO2 (325.2042)


D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators COVID info from DrugBank, clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Mrz 2266 BS

1,13-diethyl-10-[(furan-3-yl)methyl]-10-azatricyclo[7.3.1.0^{2,7}]trideca-2(7),3,5-trien-4-ol

C21H27NO2 (325.2042)


D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists

   

S-Farnesyl cysteine

2-Amino-3-[(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)sulphanyl]propanoic acid

C18H31NO2S (325.2075)


   

Antibiotic TAN 749C

Antibiotic TAN 749C

C15H27N5O3 (325.2114)


   

Daphniyunnine C

Daphniyunnine C

C21H27NO2 (325.2042)


   

CJ 13564

(E)-(-)-2-[5-(3,3-Dimethyloxiranyl)-3-methyl-2-pentenyl]-1,3-dimethyl-4(1H)-quinolinone

C21H27NO2 (325.2042)


   

Daphlongamine E

Daphlongamine E

C21H27NO2 (325.2042)


   
   

Daphnilongeranin B

Daphnilongeranin B

C21H27NO2 (325.2042)


   

ifenprodil

ifenprodil

C21H27NO2 (325.2042)


D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators COVID info from DrugBank, clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

dyshomoerythrine

dyshomoerythrine

C21H27NO2 (325.2042)


   
   

1,1-diphenyl-2,2-piperidine-2,6-diyl-bis-ethanol|2,6-Bis-(beta-hydroxy-phenaethyl)-piperidin|2,6-bis-(beta-hydroxy-phenethyl)-piperidine|Norlobelamidin|Norlobelanidin

1,1-diphenyl-2,2-piperidine-2,6-diyl-bis-ethanol|2,6-Bis-(beta-hydroxy-phenaethyl)-piperidin|2,6-bis-(beta-hydroxy-phenethyl)-piperidine|Norlobelamidin|Norlobelanidin

C21H27NO2 (325.2042)


   

ileabethoxazole

ileabethoxazole

C21H27NO2 (325.2042)


   

1-methyl-2-[7?-oxo-(E)-5?-undecenyl]-4(1H)-quinolone|euocarpine A

1-methyl-2-[7?-oxo-(E)-5?-undecenyl]-4(1H)-quinolone|euocarpine A

C21H27NO2 (325.2042)


   

1-methyl-2-[6?-oxo-(E)-7?-undecenyl]-4(1H)-quinolone|euocarpine B

1-methyl-2-[6?-oxo-(E)-7?-undecenyl]-4(1H)-quinolone|euocarpine B

C21H27NO2 (325.2042)


   
   

4Z-Isomer;B,2HCL-Sperabillin C

4Z-Isomer;B,2HCL-Sperabillin C

C15H27N5O3 (325.2114)


   
   
   

Norpropoxyphene

1,2-Diphenyl-4-(methylamino)-3-methyl-2-butanol propionate

C21H27NO2 (325.2042)


   
   
   
   
   
   
   

Norproxyphene

Norproxyphene

C21H27NO2 (325.2042)


   

9-(6-methoxynaphthalen-2-yl)oxy-3-azaspiro[5.5]undecane

9-(6-methoxynaphthalen-2-yl)oxy-3-azaspiro[5.5]undecane

C21H27NO2 (325.2042)


   

etafenone

etafenone

C21H27NO2 (325.2042)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

H-Leu-Pro-Pro-OH

L-Proline, 1-(1-L-leucyl-L-prolyl)-

C16H27N3O4 (325.2001)


   
   

(6-Amino-4,4-diphenylheptan-3-yl) acetate

(6-Amino-4,4-diphenylheptan-3-yl) acetate

C21H27NO2 (325.2042)


   

SR-59230A free base

SR-59230A free base

C21H27NO2 (325.2042)


D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists

   

Isoleucyl-prolyl-proline

Isoleucyl-prolyl-proline

C16H27N3O4 (325.2001)


   

Pro-Pro-Ile

Pro-Pro-Ile

C16H27N3O4 (325.2001)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

S-(2E,6E)-Farnesyl-L-cysteine

S-(2E,6E)-Farnesyl-L-cysteine

C18H31NO2S (325.2075)


   

2-(2,8-dihydroxytridecyl)-6-oxopyran-4-olate

2-(2,8-dihydroxytridecyl)-6-oxopyran-4-olate

C18H29O5- (325.2015)


   

2-amino-3-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]sulfanylpropanoic acid

2-amino-3-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]sulfanylpropanoic acid

C18H31NO2S (325.2075)


   

N-(1-adamantyl)-6-(3,5-dimethyl-1-pyrazolyl)-1,2,4,5-tetrazin-3-amine

N-(1-adamantyl)-6-(3,5-dimethyl-1-pyrazolyl)-1,2,4,5-tetrazin-3-amine

C17H23N7 (325.2015)


   
   

2-[4-(heptylthio)-2,5-dimethoxyphenyl]-N-methylethanamine

2-[4-(heptylthio)-2,5-dimethoxyphenyl]-N-methylethanamine

C18H31NO2S (325.2075)


   

3alpha-hydroxy-3,5-dihydro-ML-236C carboxylate

3alpha-hydroxy-3,5-dihydro-ML-236C carboxylate

C18H29O5- (325.2015)


   

L-alpha-Acetyl-N,N-dinormethadol

L-alpha-Acetyl-N,N-dinormethadol

C21H27NO2 (325.2042)


   
   
   

2-(2,3-Dihydroxybutoxy)-N-(2-(diethylamino)ethyl)-3-pyridinecarboxamide

2-(2,3-Dihydroxybutoxy)-N-(2-(diethylamino)ethyl)-3-pyridinecarboxamide

C16H27N3O4 (325.2001)


   

S-Farnesylcysteine

S-Farnesylcysteine

C18H31NO2S (325.2075)


   

Dinor-laam

L-alpha-Acetyl-N,N-dinormethadol

C21H27NO2 (325.2042)


   

S-[(2E,6E)-farnesyl]-L-cysteine zwitterion

S-[(2E,6E)-farnesyl]-L-cysteine zwitterion

C18H31NO2S (325.2075)


An amino acid zwitterion arising from transfer of a proton from the carboxy to the amino group of S-[(2E,6E)]-farnesyl-L-cysteine; major species at pH 7.3.

   

S-[(2E,6E)-farnesyl]-L-cysteine

S-[(2E,6E)-farnesyl]-L-cysteine

C18H31NO2S (325.2075)


An S-farnesyl-L-cysteine where the C=C double bonds at the 2- and 6-positions both have (E)-configuration.

   

SPHP(14:0)

SPHP(d14:0)

C14H32NO5P (325.2018)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   

(2e,4e)-n-[(2r,4r)-4-amino-5-[(2-carbamimidoylethyl)-c-hydroxycarbonimidoyl]-2-hydroxypentyl]hexa-2,4-dienimidic acid

(2e,4e)-n-[(2r,4r)-4-amino-5-[(2-carbamimidoylethyl)-c-hydroxycarbonimidoyl]-2-hydroxypentyl]hexa-2,4-dienimidic acid

C15H27N5O3 (325.2114)


   

2-[(2e)-5-[(2r)-3,3-dimethyloxiran-2-yl]-3-methylpent-2-en-1-yl]-1,3-dimethylquinolin-4-one

2-[(2e)-5-[(2r)-3,3-dimethyloxiran-2-yl]-3-methylpent-2-en-1-yl]-1,3-dimethylquinolin-4-one

C21H27NO2 (325.2042)


   

(1s,9s,13s,14r,16r,17s)-4-ethenyl-13,17-dimethyl-11-azapentacyclo[12.3.1.0¹,⁵.0⁹,¹⁷.0¹¹,¹⁶]octadec-4-ene-6,18-dione

(1s,9s,13s,14r,16r,17s)-4-ethenyl-13,17-dimethyl-11-azapentacyclo[12.3.1.0¹,⁵.0⁹,¹⁷.0¹¹,¹⁶]octadec-4-ene-6,18-dione

C21H27NO2 (325.2042)


   

2,6-dimethyl-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13-ene-15,20-dione

2,6-dimethyl-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13-ene-15,20-dione

C21H27NO2 (325.2042)


   

(2e,4z)-n-[(2r,4r)-4-amino-5-[(2-carbamimidoylethyl)-c-hydroxycarbonimidoyl]-2-hydroxypentyl]hexa-2,4-dienimidic acid

(2e,4z)-n-[(2r,4r)-4-amino-5-[(2-carbamimidoylethyl)-c-hydroxycarbonimidoyl]-2-hydroxypentyl]hexa-2,4-dienimidic acid

C15H27N5O3 (325.2114)


   

(1s,19s)-8,19-dimethoxy-13-azapentacyclo[11.7.0.0¹,¹⁶.0²,⁹.0⁴,⁷]icosa-2(9),3,7,16-tetraene

(1s,19s)-8,19-dimethoxy-13-azapentacyclo[11.7.0.0¹,¹⁶.0²,⁹.0⁴,⁷]icosa-2(9),3,7,16-tetraene

C21H27NO2 (325.2042)


   

(1r)-2-[(2s,6r)-6-[(2s)-2-hydroxy-2-phenylethyl]piperidin-2-yl]-1-phenylethanol

(1r)-2-[(2s,6r)-6-[(2s)-2-hydroxy-2-phenylethyl]piperidin-2-yl]-1-phenylethanol

C21H27NO2 (325.2042)


   

8,19-dimethoxy-13-azapentacyclo[11.7.0.0¹,¹⁶.0²,⁹.0⁴,⁷]icosa-2(9),3,7,16-tetraene

8,19-dimethoxy-13-azapentacyclo[11.7.0.0¹,¹⁶.0²,⁹.0⁴,⁷]icosa-2(9),3,7,16-tetraene

C21H27NO2 (325.2042)


   

(1r,5r,8r,9s,11r,14r,17r,18r)-5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,16-dione

(1r,5r,8r,9s,11r,14r,17r,18r)-5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,16-dione

C21H27NO2 (325.2042)


   

(1s,9s,13s,14r,17s)-4-ethenyl-13,17-dimethyl-11-azapentacyclo[12.3.1.0¹,⁵.0⁹,¹⁷.0¹¹,¹⁶]octadec-4-ene-6,18-dione

(1s,9s,13s,14r,17s)-4-ethenyl-13,17-dimethyl-11-azapentacyclo[12.3.1.0¹,⁵.0⁹,¹⁷.0¹¹,¹⁶]octadec-4-ene-6,18-dione

C21H27NO2 (325.2042)


   

(1r,2s,3r,5r,6s,10s,16s)-2,6-dimethyl-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13(19)-ene-14,20-dione

(1r,2s,3r,5r,6s,10s,16s)-2,6-dimethyl-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13(19)-ene-14,20-dione

C21H27NO2 (325.2042)


   

3-(3,7-dimethylocta-2,6-dien-1-yl)-4-methoxy-2-methylquinolin-1-ium-1-olate

3-(3,7-dimethylocta-2,6-dien-1-yl)-4-methoxy-2-methylquinolin-1-ium-1-olate

C21H27NO2 (325.2042)


   

(1s,4r,6s,7r,10r,11r,12r,16s,17r)-10-hydroxy-12-methyl-3-methylidene-8-azaheptacyclo[8.7.1.1⁴,¹⁷.1⁸,¹².0¹,⁶.0⁷,¹⁶.0¹¹,¹⁶]icosan-19-one

(1s,4r,6s,7r,10r,11r,12r,16s,17r)-10-hydroxy-12-methyl-3-methylidene-8-azaheptacyclo[8.7.1.1⁴,¹⁷.1⁸,¹².0¹,⁶.0⁷,¹⁶.0¹¹,¹⁶]icosan-19-one

C21H27NO2 (325.2042)


   

(1r,2s,3r,5r,6s,10s,16r,19s)-2,6-dimethyl-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13-ene-15,20-dione

(1r,2s,3r,5r,6s,10s,16r,19s)-2,6-dimethyl-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13-ene-15,20-dione

C21H27NO2 (325.2042)


   

2-[5-(3,3-dimethyloxiran-2-yl)-3-methylpent-2-en-1-yl]-1,3-dimethylquinolin-4-one

2-[5-(3,3-dimethyloxiran-2-yl)-3-methylpent-2-en-1-yl]-1,3-dimethylquinolin-4-one

C21H27NO2 (325.2042)


   

4-ethenyl-13,17-dimethyl-11-azapentacyclo[12.3.1.0¹,⁵.0⁹,¹⁷.0¹¹,¹⁶]octadec-4-ene-6,18-dione

4-ethenyl-13,17-dimethyl-11-azapentacyclo[12.3.1.0¹,⁵.0⁹,¹⁷.0¹¹,¹⁶]octadec-4-ene-6,18-dione

C21H27NO2 (325.2042)


   

10-hydroxy-12-methyl-3-methylidene-8-azaheptacyclo[8.7.1.1⁴,¹⁷.1⁸,¹².0¹,⁶.0⁷,¹⁶.0¹¹,¹⁶]icosan-19-one

10-hydroxy-12-methyl-3-methylidene-8-azaheptacyclo[8.7.1.1⁴,¹⁷.1⁸,¹².0¹,⁶.0⁷,¹⁶.0¹¹,¹⁶]icosan-19-one

C21H27NO2 (325.2042)


   

(1r,2s,3r,5r,6s,10s,16r,19r)-2,6-dimethyl-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13-ene-15,20-dione

(1r,2s,3r,5r,6s,10s,16r,19r)-2,6-dimethyl-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13-ene-15,20-dione

C21H27NO2 (325.2042)


   

3-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-4-methoxy-2-methylquinolin-1-ium-1-olate

3-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-4-methoxy-2-methylquinolin-1-ium-1-olate

C21H27NO2 (325.2042)


   

(1s,2s,3r,5r,6s,10s,16s)-2,6-dimethyl-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13(19)-ene-14,20-dione

(1s,2s,3r,5r,6s,10s,16s)-2,6-dimethyl-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13(19)-ene-14,20-dione

C21H27NO2 (325.2042)


   

2-[(2e)-5-(3,3-dimethyloxiran-2-yl)-3-methylpent-2-en-1-yl]-1,3-dimethylquinolin-4-one

2-[(2e)-5-(3,3-dimethyloxiran-2-yl)-3-methylpent-2-en-1-yl]-1,3-dimethylquinolin-4-one

C21H27NO2 (325.2042)


   

5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,16-dione

5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,16-dione

C21H27NO2 (325.2042)


   

(1r,5r,8r,9s,17r,18r)-5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,16-dione

(1r,5r,8r,9s,17r,18r)-5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,16-dione

C21H27NO2 (325.2042)


   

2-[6-(2-hydroxy-2-phenylethyl)piperidin-2-yl]-1-phenylethanol

2-[6-(2-hydroxy-2-phenylethyl)piperidin-2-yl]-1-phenylethanol

C21H27NO2 (325.2042)


   

2,6-dimethyl-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13(19)-ene-14,20-dione

2,6-dimethyl-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13(19)-ene-14,20-dione

C21H27NO2 (325.2042)


   

(1r,5r,8r,9s,11s,14s,17r,18r)-5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,16-dione

(1r,5r,8r,9s,11s,14s,17r,18r)-5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,16-dione

C21H27NO2 (325.2042)